RN7SL659P

Across TCGA pan-cancer cohorts, RN7SL659P RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RN7SL659P data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RN7SL659P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL659P expression acts as an unfavorable survival marker, although some lineages such as PAAD and ESCA show a favorable association.

LUSC, PAAD, and UVM are the cancer types where RN7SL659P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	II,III,IV	0.549	0.870	<.001	72	view →
PAAD	OS	Median	II,III,IV	0.558	0.341	.002	40	view →
UVM	DFS	Tertile	All	0.207	0.772	.001	36	view →
ESCA	DFS	Tertile	III,IV	0.536	0.313	.022	22	view →
KIRC	DFS	Tertile	All	0.749	0.839	.011	22	view →
CHOL	OS	Tertile	II,III,IV	0.019	0.765	.001	18	view →
THYM	OS	Tertile	IV	0.294	1.000	.025	18	view →
THCA	OS	Median	III,IV	1.000	0.945	.004	18	view →
BRCA	DFS	Median	IV	0.505	0.179	.009	17	view →
BLCA	OS	Tertile	All	0.798	0.631	.030	14	view →
MESO	OS	Median	IV	0.780	0.337	.005	12	view →
PRAD	OS	Quartile	All	0.959	1.000	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RN7SL659P–LUSC (OS)

Open the LUSC breakdown →